advanced non-small cell lung cancer

Amgen Snags Another Approval for This Promising Cancer Drug
Motley Fool
Wed, 02/16/22 - 10:48 am
Amgen
Japan
Lumakras
non-small cell lung cancer
advanced non-small cell lung cancer
Bristol-Myers makes Opdivo pitch for frontline lung cancer with open label PhIII study
Endpoints
Tue, 10/22/19 - 10:39 am
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
advanced non-small cell lung cancer
clinical trials
AstraZeneca Imfinzi combination fails advanced lung cancer study
Yahoo/Reuters
Wed, 08/21/19 - 09:31 am
AstraZeneca
Imfinzi
advanced non-small cell lung cancer
tremelimumab